摘要 |
Compounds of formula (IA) wherein R<SUB>1 </SUB>is 2-indanyl, R<SUB>2 </SUB>is 1-methylpropyl, R<SUB>3 </SUB>is 1-methyl-indazol-5-yl, R<SUB>4 </SUB>represents methyl and R<SUB>5 </SUB>represents hydrogen or methyl, and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.
|